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Abstract

Conclusion

Discussion

This work is a review and assessment of research
literature on Alzheimer’s disease (AD) today
which is an irreversible neurological disorder, that
continuously decreases the individual’s memory
and thinking skills and, suddenly, the ability to
carry out the simplest functions of daily living.
Although treatment can only help manage the
symptoms of AD, there is no cure for the disease.
CT imaging is proven to be somewhat helpful in
the detection of AD disease similar to MRI,
multiple repeat CT seems to show promise in
part-reversing the loss (radiation Hormesis). Invivo exposure, spatial distribution, and
quantitative characterization could be essential
markers in diagnosing and assessing AD
progression. Phase-Contrast X-ray microcomputed tomography (micro CT) is an emerging
highly sensitive imaging technique capable of
high resolution and impressive soft tissue
discrimination. FDG and Pittsburgh compound B
PET are functional tools to map affected brain
with AD. There is a potential to extend it to
imaging precise 3D information about the inner
structures of the entire brain in future using
clinical CT machines but with phase contrast
software without requiring thin sections.
However, we feel clinical scanners with phase
contrast modes will not provide the plaque
imaging exactly for 50 μm for individual plaques
but plaque tangles and high tissue contrast
resolution for hippocampus structures as in highfield MRI may be possible by phase contrast CT.

Blood perfusion goes everywhere, but PET radioactive agents
along with the blood remain hooked to cell walls (receptors) that
are abnormal. Chemists design that binding, but they need to
know which receptors are abnormal in AD. If they know that then
PET shows just the distribution and progression, but not the
mechanism of the disease. It loses the promise molecular imaging
provides: mechanism. PET becomes just another structural scan,
although slightly molecular and cellular relation oriented, better
than just the MRI like, tissue oriented.
PET images biochemically altered cells in the plaque. CT will image
anything that has different density and texture. CT and PET have
similar processing but different potentials. We have searched both
to explore complementary insights for AD.
We have used X-ray at low keV range (mammographic range) to
exploit the photoelectric detection of minerals in model organic
tissues like fruits (see other posters from this Lab). This is done by
designing low energy X ray beams suitable for transition metal
detection but are also filtered by passing through a solution layer
of heavy atoms (Iodine or Gadolinium). With such additional
filtration the presence of dominant alkali and alkaline earth (Ca, K,
Mg) can be overlooked.
MRI is sensitive to paramagnetic iron and manganese. Brain does
not suffer from abnormal Mn and its concentration is much less
compared to brain iron. Hence paramagnetics influence in brain
MRI images are mostly due to structural heterogeneity from bone
and air or from iron, as in deep brain gray matter nuclei.

CT has speed resolution since there are lots of
tissues that can interact with lots of external
radiation at 140kvp.
PET has lots of tissue to image but thousands of
less photons coming out from the external
injected radioisotope, at about 4 times more
energy, 500kvp.
MR imaging in AD suffers from resolution and
function detection.
Our work to selectively image abnormal iron by
MR/X-ray correlation may add insight of iron
induced plaque building in AD.
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Results
1)
2)

Materials and Methods

3)

Literature search for years 2000+ with keywords:
PET in AD, PIB PET, MicroCT and AD Plaques, Radiation
Treatment in AD, MRI in AD, Alzheimer’s Dementia.
Exclusion criteria: Articles with single modality reporting
Review articles
Inclusion criteria: AD and/or Mild Cognitive Impairment
Original research

5)

4)

6)

7)

8)

16 articles were selected that fulfilled the > 2 modalities in AD criteria
5 articles were found that met the criteria and offered AD treatment using multiple CT scans and radiation hormesis.
5 articles had mostly PET research with inadequate CT discussions and were excluded.
6 articles seem to have MR/PET or CT/PET correlations and were compared for originality and complementarity.
We have also experimented with a novel hypothesis to map iron in porous organic media as a model of neurological
medium since abnormal iron distribution is implicated in MS, AD and several other neurodegenerative disorders.
Both X ray and MRI correlations of abnormal iron overload are presented in other works in this poster session as well as in
the last two years from our laboratory.
The last project explored how to map the bio metallic state of iron in a model tissue, namely in fruits and animal tissues.
Our steps included filtering out competing biometals and selectively image bio-iron by soft mammographic X ray and high
field MRI while adding MR contrast agents like Gadolinium and iodinated CT contrast to highlight porous tissue that might
displace or store excess iron using T1-weighted contrast enhanced MRI.
We also used excess iron or tissue iron overload for susceptibility weighted MRI. Note MRI is sensitive to mild susceptibility
change due to porosity and tissue texture while MR signal and thus tissue regions are significantly dependent of iron and
manganese content that increases the local magnetic susceptibility. This results in modest MR signal increase in T1 type of
imaging as in Result # (7) while decrease the MR signal in T2 and T2* weighted MRI.

